Stratos Wealth Partners LTD. Has $346,000 Stock Position in Globe Life Inc. (NYSE:GL)

Stratos Wealth Partners LTD. trimmed its position in Globe Life Inc. (NYSE:GL) by 10.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 3,105 shares of the company’s stock after selling 353 shares during the period. Stratos Wealth Partners LTD.’s holdings in Globe Life were worth $346,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in GL. Nuance Investments LLC grew its position in shares of Globe Life by 155.6% during the 3rd quarter. Nuance Investments LLC now owns 1,138,978 shares of the company’s stock worth $120,629,000 after buying an additional 693,346 shares during the period. Swedbank AB acquired a new position in shares of Globe Life during the 4th quarter worth about $52,414,000. International Assets Investment Management LLC grew its position in shares of Globe Life by 15,398.7% during the 3rd quarter. International Assets Investment Management LLC now owns 336,631 shares of the company’s stock worth $356,530,000 after buying an additional 334,459 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Globe Life by 22.3% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,519,675 shares of the company’s stock worth $160,949,000 after buying an additional 277,108 shares during the period. Finally, Segall Bryant & Hamill LLC grew its position in shares of Globe Life by 78.5% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 290,515 shares of the company’s stock worth $30,768,000 after buying an additional 127,764 shares during the period. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

GL has been the topic of several recent analyst reports. Truist Financial lifted their price objective on Globe Life from $90.00 to $105.00 and gave the company a “hold” rating in a report on Friday, October 25th. Piper Sandler lifted their price objective on Globe Life from $118.00 to $130.00 and gave the company an “overweight” rating in a report on Friday, October 25th. BMO Capital Markets initiated coverage on Globe Life in a report on Thursday, January 23rd. They set a “market perform” rating and a $114.00 price objective on the stock. Keefe, Bruyette & Woods lifted their price objective on Globe Life from $137.00 to $145.00 and gave the company an “outperform” rating in a report on Wednesday. Finally, Jefferies Financial Group lifted their price objective on Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a report on Tuesday, December 10th. Five investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Globe Life currently has a consensus rating of “Moderate Buy” and a consensus price target of $133.10.

Insider Buying and Selling at Globe Life

In other news, CEO James Matthew Darden sold 24,890 shares of the stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $121.52, for a total transaction of $3,024,632.80. Following the sale, the chief executive officer now directly owns 38,973 shares of the company’s stock, valued at approximately $4,735,998.96. This represents a 38.97 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Frank M. Svoboda sold 13,448 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of $112.56, for a total value of $1,513,706.88. Following the sale, the chief executive officer now directly owns 18,948 shares in the company, valued at approximately $2,132,786.88. This trade represents a 41.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 64,678 shares of company stock valued at $7,454,412 in the last ninety days. 1.51% of the stock is currently owned by corporate insiders.

Globe Life Stock Up 0.0 %

GL stock opened at $121.51 on Thursday. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $10.20 billion, a PE ratio of 10.17 and a beta of 0.81. Globe Life Inc. has a 1-year low of $38.95 and a 1-year high of $132.00. The business’s 50 day simple moving average is $113.98 and its 200 day simple moving average is $107.66.

Globe Life (NYSE:GL) last posted its earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, topping analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. As a group, research analysts anticipate that Globe Life Inc. will post 13.57 EPS for the current year.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Monday, January 6th were issued a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date was Monday, January 6th. Globe Life’s dividend payout ratio is 8.03%.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.